The ferric conundrum: which intravenous iron preparations are preferred for chronic kidney disease patients?
Affiliation
College of Medicine, University of ArizonaIssue Date
2022Keywords
Chronic kidney diseaseIron deficiency anemia
Iron deposition
Iron formulation
Iron infusion
IV iron
Renal failure
Metadata
Show full item recordCitation
Hechanova, A., Mostafizi, P., Rad, K., & Tolouian, R. (2022). The ferric conundrum: Which intravenous iron preparations are preferred for chronic kidney disease patients? Journal of Nephropathology, 11(3).Journal
Journal of NephropathologyRights
Copyright © 2022 The Author(s). Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Implication for health policy/practice/research/medical education: It has been demonstrated that iron deposition in the kidney is a harbinger of poor prognosis, but it is not clear whether kidney failure/damage predisposes iron deposition, or iron deposition activates an oxidative cascade and causes kidney damage. Until this issue is clarified, it will be difficult to predict the risks or benefits of any iron infusion for chronic kidney disease. © 2022 The Author(s).Note
Open access journalISSN
2251-8363Version
Final published versionScopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2022 The Author(s). Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0).